Pfizer’s Paxlovid has been approved by US FDA for COVID treatment. Jagadeesh Babu Rangisetty, Co-founder and Managing Director at Zenara Pharma, said, "We have launched this product in India with an aim to bring the best treatment options against COVID within reach of patients in our country.
Our product, Paxzen, has been proven equivalent to Paxlovid through a Bio Equivalence study, based on which we have received the approval from the regulatory authorities." Brand name:Paxzen Manufacturer: The tablets will be manufactured at Zenara's US FDA and EU approved state-of-the-art facility in Hyderabad.
Zenara Pharma is a fully-owned subsidiary of the city-based Biophore India Pharmaceuticals Price: ₹5,200 per box Content of each box:Each box will contain 20 tablets of Nirmatrelvir 150 ml and 10 Tablets of Ritonavir 100 mg Paxlovid (Nirmatrelvir and Ritonavir) tablets can be administered to patientens with mild to moderate symptoms of Covid-19.
Meanwhile, active Covid-19 cases in India declined to 49,636, as the nation registered 6,093 new coronavirus infections by Friday afternoon taking the total tally of Covid-19 cases to 4,44,84,729, according to the Union Health Ministry data.